Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clofarabine and Low-dose Cytarabine in Elderly AML
NCT01193400Phase 2Terminated
- Sponsor
- Fundación PETHEMA
- Start
- Sep 2010
- Primary completion
- Feb 2012
- Countries
- 1
01
Overview
A Phase 2 trial of clofarabine in acute myeloid leukemia (AML), sponsored by Fundación PETHEMA. Started Sep 2010; status: terminated.
02
Drugs
clofarabine
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on NCT01193400.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01193400.